Cargando…
Biochemical and genetic analysis of butyrylcholinesterase (BChE) in a family, due to prolonged neuromuscular blockade after the use of succinylcholine
Butyrylcholinesterase (BChE) is a plasma enzyme that catalyzes the hydrolysis of choline esters, including the muscle-relaxant succinylcholine and mivacurium. Patients who present sustained neuromuscular blockade after using succinylcholine usually carry BChE variants with reduced enzyme activity or...
Autores principales: | Garcia, Daniel Fantozzi, Oliveira, Ticiano G., Molfetta, Greice A., Garcia, Luiz V., Ferreira, Cristiane A., Marques, Adriana A., Silva, Wilson Araujo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085371/ https://www.ncbi.nlm.nih.gov/pubmed/21637541 http://dx.doi.org/10.1590/S1415-47572011000100008 |
Ejemplares similares
-
Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids
por: Guimarães, Larissa O., et al.
Publicado: (2014) -
Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
por: Gu, Yan, et al.
Publicado: (2018) -
Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine
por: Zhu, Guang-dan, et al.
Publicado: (2020) -
Prolonged Neuromuscular Blockade Following Succinylcholine Administration to a Patient with a Reduced Butyrylcholinesterase Activity
por: Panhuizen, Ivo F., et al.
Publicado: (2010) -
Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations
por: Zhou, You, et al.
Publicado: (2019)